1-15 of 493
Managing Acute PE: Updates from the 2026 AHA/ACC Guideline
Heart MattersManaging Acute PE: Updates from the 2026 AHA/ACC Guideline
Mary Leuchars, MD
Mark Creager, MD
Moving Toward Precision Medicine in PAH
Clinician's RoundtableMoving Toward Precision Medicine in PAH
Stephen Y. Chan, MD, PhD, FAHA
What’s Next for Pulmonary Arterial Hypertension Care?
Clinician's RoundtableWhat’s Next for Pulmonary Arterial Hypertension Care?
Stephen Y. Chan, MD, PhD, FAHA
Evidence-Based Care for PD-L1-Negative Non-Small Cell Lung Cancer
Project Oncology®Evidence-Based Care for PD-L1-Negative Non-Small Cell Lung Cancer
Steve Jackson, PharmD
Apar Kishor Ganti, MD
Thomas Marron, MD, PhD
Axatilimab’s Impact on cGVHD and Associated BOS
Project Oncology®Axatilimab’s Impact on cGVHD and Associated BOS
Charles Turck, PharmD, BCPS, BCCCP
Amandeep Salhotra, MD
Macitentan in Pediatric PAH: Results from the TOMORROW Trial
Clinician's RoundtableMacitentan in Pediatric PAH: Results from the TOMORROW Trial
- advertisement
Early Recognition and Diagnostic Confidence in NTM Lung Disease
Clinician's RoundtableEarly Recognition and Diagnostic Confidence in NTM Lung Disease
Brian P. McDonough, MD, FAAFP
Doreen Addrizzo-Harris, MD
Emerging Data in NTM Lung Disease: Potential Impacts and Ongoing Challenges
Clinician's RoundtableEmerging Data in NTM Lung Disease: Potential Impacts and Ongoing Challenges
Alexandria May, PharmD, BCPS
David E. Griffith, MD
Managing Severe Asthma: 2026 GINA Strategy Report Recommendations
Clinician's RoundtableManaging Severe Asthma: 2026 GINA Strategy Report Recommendations
Charles Turck, PharmD, BCPS, BCCCP
Jonathan Berstein, MD
Optimizing Screening Pathways for Alpha-1 Antitrypsin Deficiency
Clinician's RoundtableOptimizing Screening Pathways for Alpha-1 Antitrypsin Deficiency
Alexandria May, PharmD, BCPS
Michael Czarnecki, MD
How to Increase Testing Rates for Alpha-1 Antitrypsin Deficiency
Clinician's RoundtableHow to Increase Testing Rates for Alpha-1 Antitrypsin Deficiency
Brian P. McDonough, MD, FAAFP
Brooks Kuhn, MD, MAS
A Phenotype-Driven Approach to Alpha-1 Antitrypsin Deficiency Care
Clinician's RoundtableA Phenotype-Driven Approach to Alpha-1 Antitrypsin Deficiency Care
Brian P. McDonough, MD, FAAFP
MeiLan Han, MD, MS
- advertisement
AI in Pulmonary Hypertension Demonstrates Progress—with Caveats
Clinician's RoundtableAI in Pulmonary Hypertension Demonstrates Progress—with Caveats
Multi-Omics Brings New Clarity to the REHAB-PH Trial
Clinician's RoundtableMulti-Omics Brings New Clarity to the REHAB-PH Trial
Targeting the Hippo Pathway in Pulmonary Arterial Hypertension
AudioAbstractsTargeting the Hippo Pathway in Pulmonary Arterial Hypertension
Ryan Quigley
